Hasil Pencarian - Lawrence G. Lum

  • Menampilkan 1 - 18 hasil dari 18
Perbaiki Hasil
  1. 1
    Mathematical Model to Predict Polyclonal T-Cell-Dependent Antibody Synthesis Responses

    Mathematical Model to Predict Polyclonal T-Cell-Dependent Antibody Synthesis Responses oleh Jagdish S. Thakur, Archana Thakur, Lawrence G. Lum

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

    Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release oleh Lawrence G Lum, Jeong A Park, Brian H Santich

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia

    Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia oleh Ewa Kubicka, Lawrence G. Lum, Manley Huang, Archana Thakur

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients

    Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients oleh Ulka Vaishampayan, Archana Thakur, Ritesh Rathore, Nicola Kouttab, Lawrence G. Lum

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity

    Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity oleh Zhaoming Wang, Chaobo Yin, Lawrence G. Lum, Andrean Simons, George J. Weiner

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines

    Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines oleh Lawrence G. Lum, Archana Thakur, Abdalla Elhakiem, Lena Alameer, Emily Dinning, Manley Huang

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Immune T cells can transfer and boost anti-breast cancer immunity

    Immune T cells can transfer and boost anti-breast cancer immunity oleh Archana Thakur, Ritesh Rathore, Sri Vidya Kondadasula, Joseph P. Uberti, Voravit Ratanatharathorn, Lawrence G. Lum

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells.

    Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. oleh Archana Thakur, Lawrence G Lum, Dana Schalk, Asfar Azmi, Sanjeev Banerjee, Fazlul H Sarkar, Ramzi Mohommad

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells

    Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells oleh Archana Thakur, John Scholler, Ewa Kubicka, Edwin T. Bliemeister, Dana L. Schalk, Carl H. June, Lawrence G. Lum

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours

    Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours oleh Manley T. F. Huang, Vikram Sharma, Andrew Mendelsohn, Qisheng Wei, Jinjing Li, Bo Yu, James W. Larrick, Lawrence G. Lum

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness

    Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness oleh Archana Thakur, Johnson Ung, Elyse N. Tomaszewski, Amy Schienschang, Timothy M. LaBrie, Dana L. Schalk, Lawrence G. Lum

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    723 Metabolically reprogrammed autologous Th1/Tc1 cell therapy (RAPA-201) yields promising safety and efficacy in post-PD-(L)1 solid tumor patients without lymphodepleting host conditioning

    723 Metabolically reprogrammed autologous Th1/Tc1 cell therapy (RAPA-201) yields promising safety and efficacy in post-PD-(L)1 solid tumor patients without lymphodepleting host con... oleh Lawrence G Lum, Martin Gutierrez, Sunil Patel, Michele Donato, Jee Hyun Park, Tania Felizardo, Daniel H Fowler, Morgan Finlay, Ronit Reich-Slotky, Research Nurse Coordinator

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer

    Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer... oleh Michael Simon, Lawrence Flaherty, Lawrence G. Lum, Archana Thakur, Abhinav Deol, Kristie Fields, Dana Schalk, Zaid Al-Kadhimi, Vidya Kondadasula, Elyse Tomashewski, Patricia Steele, Melissa Giroux

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients

    Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients oleh Lawrence G. Lum, Archana Thakur, Minsig Choi, Abhinav Deol, Vidya Kondadasula, Dana Schalk, Kristie Fields, Melissa Dufrense, Philip Philip, Gregory Dyson, Hussein D. Aon, Anthony F. Shields

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells

    Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells oleh Qin Liu, Archana Thakur, Lawrence G Lum, Dana Schalk, Anthony F Shields, Daniel W Lee, Nai-Kong V Cheung, Maxim Yankelevich, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Amy Schienshang, Sarah Whitaker, Katie Rea

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity

    Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity oleh Mary L. Faber, Robyn A. A. Oldham, Robyn A. A. Oldham, Archana Thakur, Mary Jo Rademacher, Ewa Kubicka, Theresa A. Dlugi, Steven A. Gifford, William M. McKillop, Nathan J. Schloemer, Lawrence G. Lum, Jeffrey A. Medin, Jeffrey A. Medin, Jeffrey A. Medin

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile

    Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile oleh Jeffrey M. Sturek, Tania A. Thomas, James D. Gorham, Chelsea A. Sheppard, Allison H. Raymond, Kristen Petros De Guex, William B. Harrington, Andrew J. Barros, Gregory R. Madden, Yosra M. Alkabab, David Y. Lu, Qin Liu, Melinda D. Poulter, Amy J. Mathers, Archana Thakur, Dana L. Schalk, Ewa M. Kubicka, Lawrence G. Lum, Scott K. Heysell

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    629-E Randomized trial comparing conventional vs novel treatment planning technique to improve the immune system during lung SBRT

    629-E Randomized trial comparing conventional vs novel treatment planning technique to improve the immune system during lung SBRT oleh Archana Thakur, Lawrence G Lum, David Cousins, Mark R Conaway, Jason Sanders, Krishni Wijesooriya, James M Larner, Paul W Read, Timothy N Showalter, Cam Nguyen, David W Lain, Kara Romano, Christopher M McLaughlin, Christopher K Luminais, Einsley Janowski, Donald Muller, Kristin Ward, Sunil Dutta, Song Wood, Joe Chen, Ebenezer Asare, Emily Nesbit, Yhana C Chavis, Kristin V Walker

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: